Roundup Exposure May Increase Infertility, Endometriosis Risks: Study

Roundup Exposure May Increase Infertility, Endometriosis Risks Study

Data from a new study warns that exposure to Roundup and other used glyphosate-based weed killers may have adverse effects on the human female reproductive system, raising further concerns about the widely used herbicides.

The findings, which come after decades of the weedkiller’s use around the globe, were published in Reproductive Sciences earlier this year, linking glyphosate exposure to oxidative stress, hormonal disruption, and cellular changes in ovarian and uterine tissues that may impair fertility and elevate the risk of endometriosis.

Glyphosate is the active ingredient in Roundup, which has been commonly used for decades in the agricultural industry, as well as for residential purposes as a weed killer. Although it has been marketed as safe for humans, research over the last several years has linked Roundup exposure to an increased risk of non-Hodgkin’s lymphoma and other adverse health effects.

As a result of the manufacturers’ failure to warn about the potential cancer risks, Bayer and its Monsanto subsidiary have faced more than 120,000 Roundup lawsuits, each raising similar allegations that users developed non-Hodgkin’s lymphoma from the weed killer, either when using the product in an agricultural setting or around the home.

After spending more than $10 billion in Roundup settlements, Bayer announced in 2021 that it would reformulate Roundup and remove the active ingredient glyphosate from consumer versions of the weed killer. However, glyphosate is still in the formulation for agricultural users, potentially leading to increased risks of cancer and other adverse health conditions for those coming in contact with the product.

Roundup-Cancer-Lawsuit-Lawyer
Roundup-Cancer-Lawsuit-Lawyer

In this new study, researchers from Wayne State University conducted a review of literature on glyphosate-based herbicides (GBHs) up to March 2024. They looked for effects on the female reproductive system and the possible clinical implications.

According to their data, glyphosate (GLY) exposure can cause tissue changes in the ovaries and uterus that may make it more difficult to become pregnant. In addition, glyphosate can disrupt the human endocrine system, which governs the distribution of hormones.

These conditions can lead to polycystic ovary syndrome (PCOS) and endometriosis, the researchers warned. They also noted that Roundup exposure side effects could also disrupt embryo implantation by damaging blood flow to the uterus, which can “increase the risk of adverse pregnancy outcomes and warrant further investigation.”

The researchers also noted that past studies have demonstrated adverse effects on male reproduction as well, including lower sperm count, developmental delays and hormonal changes.

“GLY adversely affects the female reproductive system through increased oxidative stress, endocrine disruption of reproductive hormones, histological changes in ovarian and uterus tissue, and diminished ovarian function in human cell lines and animals,” the researchers determined. “We conclude that increased research efforts are warranted regarding the safety and efficacy of GBH as it pertains to female reproduction, as well as investments in cost-effective alternatives with the potential to reduce GBH usage.”


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design.
A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims.